Deal Library / Pharma BD Deal Intelligence

Takeda Pharmaceutical Company Ltd. — Pharma Deals

The Pharma Closeout tracks 12 deals, $118.1B in disclosed deal value, 10 with a post-close Outcome Score for Takeda Pharmaceutical Company Ltd..

Median Critic Score: 77 · Median Outcome Score: 55

All 12 deals

Takeda Pharmaceutical Company Ltd. / Nimbus Lakshmi — 2022 · $6.0B · Worked — the deal delivered on its rationale.
Takeda Pharmaceutical Company Ltd. / Millennium Pharmaceuticals — 2003 · $8.8B · Worked — the deal delivered on its rationale.
Takeda Pharmaceutical Company Ltd. / Ariad Pharmaceuticals — 2003 · $5.2B · Worked — the deal delivered on its rationale.
Takeda Pharmaceutical Company Ltd. / Nycomed — 2011 · $13.7B · Largely worked — most objectives met.
Takeda Pharmaceutical Company Ltd. / Denali Therapeutics Inc. — 2018 · $1.2B · Largely worked — most objectives met.
Takeda Pharmaceutical Company Ltd. / URL Pharma, Inc. — 2012 · $800M · Mixed — partial payoff, real shortfalls.
Takeda Pharmaceutical Company Ltd. / Intellikine, Inc. — 2011 · $310M · Underwhelmed — fell short of the thesis.
Takeda Pharmaceutical Company Ltd. / Wave Life Sciences Ltd. — 2018 · $2.0B · Did not work — the deal failed to deliver.
Takeda Pharmaceutical Company Ltd. / TiGenix NV — 2018 · $640M · Did not work — the deal failed to deliver.
Takeda Pharmaceutical Company Ltd. / Shire plc — 2018 · $62.0B · Did not work — the deal failed to deliver.
Takeda Pharmaceutical Company Ltd. / Innovent Biologics, Inc. — 2025 · $11.4B
Takeda Pharmaceutical Company Ltd. / Nimbus Therapeutics (Lakshmi subsidiary, TYK2 program) — 2022 · $6.0B